When the letter from a pharmacy owner went viral on Chinese social media in September, it sparked a heated debate about what it meant for the world of Chinese healthcare.
But it also sparked a backlash, as Chinese pharmacists across the country began refusing to accept the letter.
The letter, written by the owner of a pharmacery in China’s southern province of Sichuan, said that his business had been forced to close down after Chinese authorities took over the pharmacy.
The letter said that in order to pay for their bills, they had to stop sending prescriptions.
They could no longer be trusted.
“This is our livelihood.
This is our lives.
We have to fight for it,” the letter reads.
“And it’s not just us, because this is the people who have the most to lose.”
The pharmacist, who has not been identified, wrote that he has had to close his shop and hire other workers to fill the gap.
But he also said that if the Chinese government wants to force their way into the pharmaceutical industry, he doesn’t want to see his own children suffer, either.
It was only after Chinese President Xi Jinping visited Shanghai, and made it clear that he would take control of all Chinese healthcare systems, that the pharmacist started to worry about the repercussions of Chinese authorities controlling his pharmacy.
In a letter to the pharmacy, the owner said that it was important that pharmacists take the necessary steps to protect themselves, his employees and customers.
He also wrote that his employees had been told that they were required to stop communicating with customers, and to refuse to pay their bills.
Chinese pharmacists and pharmacists in other parts of China were also forced to cut staff by half, and the number of employees required to be on call doubled.
Even though Chinese authorities have said that they will not tolerate a pharmacy that sells its products to foreign customers, pharmacists have not been able to prevent foreign drug imports from flowing into their country.
China has a history of taking a hard line with pharmaceutical companies, even though the country’s overall healthcare system has improved dramatically in the past decade.
China has one of the world’s highest per capita life expectancies, and is the world leader in the development of medical equipment and the supply of new drugs.
This has made it an attractive market for pharmaceutical companies to set up shop in China.
In 2012, a study by the International Narcotics Control Board (INCB) found that China’s pharmaceutical industry had received $8.4 billion in U.S. drug export licenses, more than any other country.
The U.K.-based think tank, the Royal Pharmaceutical Society, estimated that China would account for almost two-thirds of global pharmaceutical sales by 2035.
The Chinese government has also made it very clear that it will not allow Chinese manufacturers to sell their products in the U.B.C. It will, however, allow Chinese companies to sell products through a designated export control agency.